Pancreatic cancer is the fourth leading cause of cancer deaths. Since the majority of patients present with incurablemetastatic disease, novel imaging methods are needed to identify pancreatic cancer and assess response to therapy.Research presented at the 2013 American Society of Oncology (ASCO) Annual Meeting provided insight into potentialimaging methods. We discuss Abstracts #4049, #TPS4144, #TPS4146, and #E15069 in this paper.
Muhammad Wasif Saif, Saravanan Kokila Krishnamoorthy, Morris Hayim, Tyler Vestal
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : September 22, 2019